With the help of exercise, a better diet, a lot of determination, and a GLP-1 medication, Jeanne Erland lost 164 pounds over ...

"I’m the one that has to live in my body, I’m doing what I need to get my life back, and that’s all that matters." ...

A new case report highlights the potential risk of "anhedonia" from high doses of tirzepatide, though it can be treated ...

Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist medication approved by the Food and Drug Administration (FDA) to treat type 2 diabetes. While providers may prescribe this drug off label ...

America is slimming down — one shot at a time. The number of US adults turning to blockbuster GLP-1 drugs like Ozempic and ...

Serena Williams' weight loss is, in part, due to her use of GLP1s.

Podiatrists across the U.S. are warning GLP-1 users about "Ozempic feet" - painful foot changes caused by rapid fat pad loss.

After a lackluster first half of 2025, healthcare stocks staged a comeback, posting the best performance among the 11 S&P 500 sectors over the past six months. In large part, that rebound was fueled ...

Add Yahoo as a preferred source to see more of our stories on Google. During a press conference in the Oval Office and surrounded by many of his most senior aides, including HHS Secretary Robert ...

What Are GLP-1 Drugs? Injectable GLP-1 (glucagon-like peptide-1) receptor agonists were first introduced for managing Type 2 diabetes, a condition that affects over a quarter of Medicare beneficiaries ...

For years, GLP-1 drugs like Wegovy and Zepbound have transformed the discussion around obesity — but left millions locked out by high price tags, including Medicare recipients. That changes this week.